Acute paraplegia in a patient with eosinophilic granulomatosis and polyangiitis with 20 years of evolution: case report

Acute paraplegia in a patient with eosinophilic granulomatosis and polyangiitis with 20 years of evolution: case report


  • Mariana Guerra a:1:{s:5:"en_US";s:43:"Centro Hospitalar Universitário de Coimbra";}
  • Daniela Marado
  • Jorge Fortuna


Eosinophilic granulomatosis with polyangiitis, Churg-Strauss vasculitis, Spinal epidural lipomatosis, Myelopathy, Systemic glucocorticoids, Anti-neutrophil cytoplasmic antibodies, Central nervous system


Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare and necrotizing vasculitis of small and medium vessels with a heterogeneous presentation, multiorgan involvement, characterized by the presence of chronic rhinosinusitis, asthma, and peripheral eosinophilia. Nervous system involvement is frequent, especially in the peripheral nervous system (PNS), in the form of mononeuritis multiplex. However, subarachnoid and cerebral hemorrhage, cerebral infarction, cranial nerve palsies, and cortical blindness have also been reported in the literature. Initial therapy involves systemic GC, which are not free of complications.

We present the case of a patient with EGPA of more than 20 years duration who suddenly developed bilateral paresthesia of the lower limbs and urinary retention. The neurological exam revealed paraplegia with a sensorial level in D4; the MRI showed spinal cord compression in the D2-D7 level, and the patient was emergently submitted to surgical decompression. The histopathology of the surgical specimen demonstrated the presence of epidural adipose tissue with multiple vasculitic lesions.

The effects of systemic corticosteroid therapy may contribute to abnormal fat deposition in various body segments, including the neuroaxis, leading to the development of epidural lipomatosis. However, the intra-lesional vasculitic character is a unique manifestation of myelopathy that has shown us to have a more aggressive attitude.


Author Biographies

Daniela Marado



Jorge Fortuna




Groh M, Pagnoux C, Baldini C, et al. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (EGPA) Consensus Task Force recommendations for evaluation and management. Eur J Intern Med. 2015;26(7):545-553. doi: 10.1016/j.ejim.2015.04.022

Furuta S, Iwamoto T, Nakajima H. Update on eosinophilic granulomatosis with polyangiitis. Allergol Int. 2019;68(4):430-436. doi:10.1016/j.alit.2019.06.004

CHURG J, STRAUSS L. Allergic granulomatosis, allergic angiitis, and periarteritis nodosa. Am J Pathol. 1951;27(2):277-301.

Churg A. Pulmonary angiitis and granulomatosis revisited. Hum Pathol. 1983;14(10):868-883. doi:10.1016/s0046-8177(83)80162-2

Comarmond C, Pagnoux C, Khellaf M, et al. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): clinical characteristics and long-term follow-up of the 383 patients enrolled in the French Vasculitis Study Group cohort. Arthritis Rheum. 2013;65(1):270-281. doi:10.1002/art.37721

Diny NL, Rose NR, Čiháková D. Eosinophils in Autoimmune Diseases. Front Immunol. 2017;8:484. Published 2017 Apr 27. doi:10.3389/fimmu.2017.00484

André R, Cottin V, Saraux JL, et al. Central nervous system involvement in eosinophilic granulomatosis with polyangiitis (Churg-Strauss): Report of 26 patients and review of the literature. Autoimmun Rev. 2017;16(9):963-969. doi: 10.1016/j.autrev.2017.07.007

Chung SA, Langford CA, Maz M, et al. 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. Arthritis Rheumatol. 2021;73(8):1366-1383. doi:10.1002/art.41773

Lévy-Weil FE, Feldmann JL. Lipomatose épidurale [Epidural lipomatosis]. Presse Med. 2000;29(9):469-475.

Artner J, Leucht F, Cakir B, Reichel H, Lattig F. Spinale epidurale Lipomatose [Spinal epidural lipomatosis]. Orthopade. 2012;41(11):889-893. doi:10.1007/s00132-012-1966-z

Jalladeau E, Carpentier AF, Napolitano M, Delattre JY. Lipomatose epidurale cortico-induite [Corticosteroid-induced epidural lipomatosis]. Rev Neurol (Paris). 2000;156(5):517-519.

Keogh KA, Specks U. Churg-Strauss syndrome. Semin Respir Crit Care Med. 2006;27(2):148-157. doi:10.1055/s-2006-939518

Mohammad AJ. An update on the epidemiology of ANCA-associated vasculitis. Rheumatology (Oxford). 2020;59(Suppl 3): iii42-iii50. doi:10.1093/rheumatology/keaa089

Lanham JG, Elkon KB, Pusey CD, Hughes GR. Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome. Medicine (Baltimore). 1984;63(2):65-81. doi:10.1097/00005792-198403000-00001

Guillevin L, Cohen P, Gayraud M, Lhote F, Jarrousse B, Casassus P. Churg-Strauss syndrome. Clinical study and long-term follow-up of 96 patients. Medicine (Baltimore). 1999;78(1):26-37. doi:10.1097/00005792-199901000-00003

Zheng Y, Zhang Y, Cai M, Lai N, Chen Z, Ding M. Central Nervous System Involvement in ANCA-Associated Vasculitis: What Neurologists Need to Know. Front Neurol. 2019; 9:1166. Published 2019 Jan 10. doi:10.3389/fneur.2018.01166

Walker PB, Sark C, Brennan G, Smith T, Sherman WF, Kaye AD. Spinal Epidural Lipomatosis: A Comprehensive Review. Orthop Rev (Pavia). 2021;13(2):25571. Published 2021 Jul 11. doi:10.52965/001c.25571







How to Cite

Acute paraplegia in a patient with eosinophilic granulomatosis and polyangiitis with 20 years of evolution: case report . Acta Biomed [Internet]. 2023 Dec. 5 [cited 2024 Jun. 19];94(6):e2023243. Available from: